Skip to content
BOOM! Healthcare Communications

Therapy areas

We know the science. And the people it affects.

More than 70 therapy areas across 300+ brands. Some of our experience runs especially deep, and it shows in the questions we ask before we write a word.

brands
300+brands
brand launches
50+brand launches
therapy areas
70+therapy areas
completed projects
1,000+completed projects

Where we go deepest

The harder the science, the more we enjoy it.

This is where our experience runs deepest. Each area has its own language, its own specialists and its own reasons why a message lands or doesn't.

Oncology and haematology

Why it’s hardFast-moving data, complex mechanisms and treatment decisions with very high stakes.

What we’ve worked onCAR-T and cell therapy launches, leukaemias, lymphomas, myeloma, breast, lung and prostate cancer.

Immunology

Why it’s hardMany treatment options, and patients who have often tried several already.

What we’ve worked onCrohn's and ulcerative colitis, lupus, psoriatic and rheumatoid arthritis, HLH.

Neurology

Why it’s hardLong journeys, outcomes that are hard to measure and carers who are part of every decision.

What we’ve worked onMultiple sclerosis, Parkinson's, Alzheimer's, epilepsy, migraine, post-stroke spasticity.

Rare disease

Why it’s hardSmall populations, few specialists and every word under scrutiny.

What we’ve worked onGaucher disease, acromegaly, primary HLH, beta thalassaemia, haemophilia.

Medical devices

Why it’s hardAudiences who buy on evidence and technique, not mechanism of action.

What we’ve worked onBiosurgery, fibrin sealants, haemostatic matrices, surgery and wound care.

Who we talk to

We know who’s on the other side of the message.

  • Specialist doctors. Busy, sceptical and fluent in the data. We respect their time and their intelligence.
  • Nurses and pharmacists. Often the people who make treatment work day to day.
  • Payers and market access. Our founder worked in market access at Novartis, so value stories are second nature.
  • Patients and carers. People first, diagnosis second.
  • Your own teams. Sales and medical colleagues who need to understand the story before they can tell it.

Global, regional, local

One idea. Many markets.

We work at global, regional and local level, including emerging markets. With teams in the UK and Copenhagen, we know how a global idea needs to change to work in a local market, and how to keep it approved along the way.

Specialist knowledge

  • Rare disease
  • Biosimilars
  • Brand substitution
  • Generics
  • Multi-indication therapies

The full list

18 specialisms. 70+ therapy areas.

Search by condition, treatment or abbreviation.

18 specialisms covering 70+ therapy areas

  • Cardiovascular

    Hypertension, Surgery, Diabetes

  • Dermatology

    Psoriasis, Eczema, Actinic Keratosis, Fungal Nail & Skin Infections

  • Endocrinology

    Interventional, Acromegaly, GHD (growth hormone deficiency), Hyperhidrosis

  • Haematology

    Beta Thalassemia, Haemophilia, Stem Cell Mobilisation, ALCL, AML, APML, CLL, CML, DLBCL, FL, HL, MM

  • Hepatic

    Hepatitis B, Hepatitis C

  • Immunology

    Crohn's & UC (ulcerative colitis), HLH, Lupus, Psoriatic Arthritis, Rheumatoid Arthritis

Got a brief in one of these areas?

Tell us the challenge. We'll put the right people around it.

Start a conversation